The abstract is read at the publisher; the summary is JClub's.
GBA1-related Parkinson’s disease shows accelerated, domain-general cognitive decline versus GBA1-wildtype, with earliest impairments in processing speed and visuoperceptual.
- Why it matters: People with Parkinson’s disease carrying pathogenic GBA1 variants have higher cognitive impairment risk, but the timing and progression across cognitive domains were unclear.
- What they did: Across PPMI, ABC-PD, and NCER-PD, standardized neuropsychological testing in 546 controls, 903 GBA1-wildtype, and 211 GBA1 carriers was modeled with GLMMs, latent trajectory analysis, and time-to-first-event models using z≤-1.5 and MoCA<26.
- The result: At baseline and over follow-up, GBA1 carriers performed worse in executive function, attention, visuocognitive skills, and memory, with earlier processing speed impairment by 1.2 disease years and visuoperceptual by 2.5; a rapidly declining subgroup was linked to male sex, depressive symptoms, and severe GBA1 mutations.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.